Man hit by Cadillac in Chesterfield dies
Lawmakers scramble for deal amid shutdown
3 things you can do as Facebook makes big changes

What’s the gene that led to Angelina Jolie’s double mastectomy?

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

(CNN) — Angelina Jolie’s stunning announcement that she had a preventive double mastectomy raised both awareness and questions about the gene that led to her decision — BRCA1.

So what is the gene, and how can it increase a woman’s risks for breast and ovarian cancers? A primer:

What is BRCA1?

BRCA1 and BRCA 2 are types of tumor-suppressing genes, according to the National Cancer Institute. In normal cells, those genes help stabilize the cell’s DNA and help prevent uncontrollable cell growth. But if the genes have a harmful mutation, they can lead to breast or ovarian cancer.

What do BRCA1 and BRCA2 stand for?

The acronyms stem from the full names of the genes: breast cancer susceptibility gene 1 and breast cancer susceptibility gene 2.

What’s the difference between BRCA1 and BRCA2?

The genes are very similar. But harmful mutations in BRCA1 can lead to breast cancers that are harder to treat because they don’t respond to hormone therapies used to treat tumors that occur more often in women with BRCA2 mutations, according to The Breast Care Site.

What’s the likelihood of getting breast or ovarian cancer if you have a BRCA mutation?

About 12% of all women will develop breast cancer sometime in their lives, the National Cancer Institute says. But for women with a harmful BRCA mutation, the risk of breast cancer quintuples to 60%.

As for ovarian cancer, about 1.4% of women will have the disease sometime in their lives. But the risk for women with a harmful BRCA mutation increases to 15% to 40%.

How can you tell if you have BRCA1 and BRCA2 mutations?

A blood test at a hospital or doctor’s office can help detect BRCA1 and BRCA2 mutations, according to the National Cancer Institute. Results could take several weeks, as the test must be performed by a laboratory that specializes in the screening.

But testing can cost anywhere from several hundred to several thousand dollars, and insurance companies may or may not cover the cost.

Only women with increased risk from family history are likely to benefit from such genetic testing, according to the Centers for Disease Control and Prevention. Only 3% to 5% of women who develop breast cancer have a BRCA mutation, and about 10% to 15% of women with ovarian cancer have a BRCA mutation.

Can BRCA abnormalities affect men?

Yes. Although only 1% of all breast cancers occur in men, having a BRCA mutation means an increased risk, particularly for men with BRCA2, according to The Breast Care Site. Harmful BRCA mutations also raise a man’s chance of developing cancer of the pancreas, skin or prostate.